Chlamydia psittaci in ocular adnexa MALT lymphoma: A possible role in lymphomagenesis and a different geographical distribution

Infectious Agents and Cancer

Volumn 7, Issue 1, 2012, Pages

  Collina, Francesca ^a   De Chiara, Anna ^a   De Renzo, Amalia ^b   De Rosa, Gaetano ^b   Botti, Gerardo ^a   Franco, Renato ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

bcl10; Chlamydia psittaci; MALT lymphoma; Ocular Adnexa; t(14; 18)

Indexed keywords

ALPHA INTERFERON; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DOXORUBICIN; DOXYCYCLINE; FLUDARABINE; PREDNISONE; RITUXIMAB; VINCRISTINE;

AFRICA; ANTIBIOTIC THERAPY; ARTICLE; AUSTRIA; BORRELIA BURGDORFERI; CAMPYLOBACTER JEJUNI; CANCER COMBINATION CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CELL INVASION; CHINA; CHLAMYDOPHILA PSITTACI; CHROMOSOME 18; CHROMOSOME 3; CHROMOSOME ABERRATION; CLINICAL FEATURE; COMPARATIVE GENOMIC HYBRIDIZATION; COMPUTER ASSISTED TOMOGRAPHY; CUBA; DIFFERENTIAL DIAGNOSIS; DIPLOPIA; ECHOGRAPHY; EPIPHORA; EXOPHTHALMOS; EYE MOVEMENT DISORDER; FOLLICULAR LYMPHOMA; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; GERMANY; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INCIDENCE; ITALY; JAPAN; KOREA; LYMPHOMA CELL; LYMPHOPROLIFERATIVE DISEASE; MANTLE CELL LYMPHOMA; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NETHERLANDS; NUCLEAR MAGNETIC RESONANCE IMAGING; OCULAR ADNEXA MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; ORBIT EDEMA; OVERALL SURVIVAL; PATHOGENESIS; PRIORITY JOURNAL; PTOSIS; RECURRENCE FREE SURVIVAL; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; TREATMENT RESPONSE; UNITED KINGDOM; UNITED STATES;

EID: 84859148862     PISSN: None     EISSN: 17509378     Source Type: Journal    
DOI: 10.1186/1750-9378-7-8     Document Type: Article

References (126)

1. Malignant tumors of the orbit. Analysis of the Florida cancer registry. Margo CE, Mulla ZD, Ophthalmology 1998 105 1 185 190 10.1016/S0161-6420(98) 92107-8 9442797 (Pubitemid 28070620)
2. Non-Hodgkin's lymphoma of the ocular adnexa. Sasai K, Yamabe H, Dodo Y, Kashii S, Nagata Y, Hiraoka M, Acta Oncol 2001 40 4 485 490 11504308 (Pubitemid 32682033)
3. Clinical, histopathological, and immunogenetic analysis of ocular adnexal lymphoproliferative disorders: characterization of malt lymphomaMod. Mannami T, Yoshino T, Oshima K, Takase S, Kondo E, Ohara N, Nakagawa H, Ohtsuki H, Harada M, Akagi T, Pathol 2001 14 7 641 649 (Pubitemid 32667207)
4. Rapidly increasing incidence of ocular non-Hodgkin lymphoma. Moslehi R, Devesa SS, Schairer C, Fraumeni JF Jr, J Natl Cancer Inst 2006 98 13 936 939 10.1093/jnci/djj248 16818858 (Pubitemid 44018924)
5. Nuclear bcl10 expression characterizes a group of ocular adnexa MALT lymphomas with shorter failure-free survival. Franco R, Camacho FI, Caleo A, Staibano S, Bifano D, De Renzo A, Tranfa F, De Chiara A, Botti G, Merola R, Diez A, Bonavolont G, De Rosa G, Piris MA, Mod Pathol 2006 19 1055 1067 16648871 (Pubitemid 44106721)
6. MALT lymphoma: recent advances in aetiology and molecular genetics. Du MQ, J Clin Exp Hematophatol 2007 47 2 31 42 10.3960/jslrt.47.31
7. High incidence of primary gastric lymphoma in northeastern Italy. Doglioni C, Wotherspoon A, Moschini A, De Boni M, Isaacson PG, Lancet 1992 339 834 835 10.1016/0140-6736(92)90280-G 1347858
8. Helicobacter pylori infection and gastric lymphoma. Parsonnet J, Hansen S, Rodriguez L, Gelb AB, Warnke RA, Jellum E, Orentreich N, Vogelman JH, Friedman GD, N Engl J Med 1994 330 1267 1271 10.1056/NEJM199405053301803 8145781 (Pubitemid 24129959)
9. Immunoproliferative small intestinal disease associated with Campylobacter jejuni. Lecuit M, Abachin E, Martin A, Poyart C, Pochart P, Suarez F, Bengoufa D, Feuillard J, Lavergne A, Gordon JI, Berche P, Guillevin L, Lortholary O, N Engl J Med 2004 350 239 248 10.1056/NEJMoa031887 14724303 (Pubitemid 38067636)
10. Positive serology for Lyme disease borrelias in primary cutaneous B-cell lymphoma: a study in 22 patients; is it a fortuitous finding? Jelic S, Filipovic-Ljeskovic I, Hematol Oncol 1999 17 107 116 10.1002/(SICI)1099- 1069(199909)17:3<107::AID-HON644>3.0.CO;2-R 10641031 (Pubitemid 30094131)
11. Evidence for an association between chlamydia psittaci and ocular adnexal lymphoma. Ferreri AJ, Guidoboni M, Ponzoni M, De Conciliis C, Dell'Oro S, Fleischhauer K, Caggiari L, Lettini AA, Dal Cin E, leri R, Freschi M, Villa E, Boiocchi M, Dolcetti R, J Natl Cancer Inst 2004 96 586 594 10.1093/jnci/djh102 15100336 (Pubitemid 38584982)
12. Regression of ocular adnexal lymphoma after Chlamydia psittaci-eradicating antibiotic therapy. Ferreri AJ, Ponzoni M, Guidoboni M, De Conciliis C, Resti AG, Mazzi B, Lettini AA, Demeter J, Dell'Oro S, Doglioni C, Villa E, Boiocchi M, Dolcetti R, J Clin Oncol 2005 23 5067 5073 10.1200/JCO.2005.07.083 15968003 (Pubitemid 46224014)
13. Chlamydia psittaci infection and clinicopathologic analysis of ocular adnexal lymphomas in Korea. Yoo C, Ryu MH, Huh J, Park JH, Kang HJ, Ahn HS, Lee Y, Kim MJ, Lee H, Kim TW, Chang HM, Lee JL, Kang YK, Am J Hematol 2007 82 821 823 10.1002/ajh.20962 17570512 (Pubitemid 350194513)
14. Chlamydia psittaci in MALT lymphomas of ocular adnexals: the Austrian experience. Aigelsreiter A, Leitner E, Deutsh A, Kessler HH, Stelzl E, Beham-Schmid C, Beham A, Krugmann J, Dinges HP, Linkesch W, Neumeister P, Leuk Res 2008 32 1292 1294 10.1016/j.leukres.2007.10.013 18061259 (Pubitemid 351626920)
15. Chlamydia psittaci is variably associated with ocular adnexal MALT lymphoma in different geographical regions. Chanudet E, Zhou Y, Bacon CM, Wotherspoon AC, Müller-Hermelink HK, Adam P, Dong HY, de Jong D, Li Y, Wei R, Gong X, Wu Q, Ranaldi R, Goteri G, Pileri SA, Ye H, Hamoudi RA, Liu H, Radford J, Du MQ, J Pathol 2006 209 3 344 351 10.1002/path.1984 16583361 (Pubitemid 43997743)
16. Low prevalence of Chlamydia psittaci in ocular adnexal lymphomas from Cuban patients. Gracia E, Froesch P, Mazzucchelli L, Martin V, Rodríguez-Abreu D, Jiménez J, Melgares M, Santos D, Capá V, Cavalli F, Zucca E, Bertoni F, Leuk Lymphoma 2007 48 1 104 108 10.1080/10428190600908174 17325853 (Pubitemid 46978629)
17. Geographic variation and environmental conditions as cofactors in Chlamydia psittaci association with ocular adnexal lymphomas: a comparison between Italian and African samples. Carugi A, Onnis A, Antonicelli G, Rossi B, Mannucci S, Luzzi A, Lazzi S, Bellan C, Tosi GM, Sayed S, De Falco G, Leoncini L, Hematol Oncol 2010 28 1 20 26 19728399
18. Is there an association between ocular adnexal lymphoma and infection with Chlamydia psittaci? The University of Rochester experience. Vargas RL, Fallone E, Felgar RE, Friedberg JW, Arbini AA, Andersen AA, Rothberg PG, Leukemia Res 2006 30 547 551 10.1016/j.leukres.2005.09.012 (Pubitemid 43374583)
19. Ocular adnexal lymphoma: a clinicopathologic study of a large cohort of patients with no evidence for an association with Chlamydia psittaci. Rosado MF, Byrne GE Jr, Ding F, Fields KA, Ruiz P, Dubovy SR, Walker GR, Markoe A, Lossos IS, Blood 2006 107 467 472 10.1182/blood-2005-06-2332 16166588 (Pubitemid 43076366)
20. Ocular adnexal mucosa-associated lymphoid tissue lymphoma in Northern China: high Frequency of numerical chromosomal changes and no evidence of an association with Chlamydia psittaci. Zang D, Dong L, Li H, Jin H, Ye H, Zhou X, Gao Z, Dong G, Zhu J, Liu H, Gong L, Leuk Lymphoma 2010 51 11 2031 2038 10.3109/10428194.2010.513751 20807089
21. Ocular adnexal lymphoma: no evidence for bacterial DNA associated with lymphoma pathogenesis. Matthews JM, Moreno LI, Dennis J, Byrne GE Jr, Ruiz P, Dubovy SR, Lossos IS, Br J Haematol 2008 142 246 249 10.1111/j.1365-2141.2008. 07112.x 18492114 (Pubitemid 351987310)
22. Absence of Chlamydial infection in Japanese patients with ocular adnexal lymphoma of mucosa-associated lymphoid tissue. Yakushijin Y, Kodama T, Takaoka I, Tanimoto K, Bessho H, Sakai I, Hato T, Hasegawa H, Yasukawa M, Int J Hematol 2007 85 223 230 10.1532/IJH97.06065 17483059 (Pubitemid 46686582)
23. Chlamydia psittaci in ocular adnexal lymphoma: Japanese experience. Liu YC, Ohyashiki JH, Ito Y, Iwaya K, Serizawa H, Mukai K, Goto H, Usui M, Ohyashiki K, Leuk Res 2006 30 12 1587 1589 10.1016/j.leukres.2006.01.015 16524626 (Pubitemid 44573472)
24. No evidence for an association of ocular adnexal lymphoma with Chlamydia psittaci in a cohort of patients from the Netherlands. Mulder MM, Heddema ER, Pannekoek Y, Faridpooya K, Oud ME, Schilder-Tol E, Saeed P, Pals ST, Leuk Res 2006 10 1305 1307 (Pubitemid 44223720)
25. Low prevalence of Chlamydia psittaci infection in french patients with ocular adnexal lymphomas. De Cremoux P, Subtil A, Ferreri AJ, Vincent-Salomon A, Ponzoni M, Chaoui D, Arnaud P, Lumbroso-Le Rouic L, Sacchetti F, Dendale R, Thioux M, Escande MC, Stern MH, Dolcetti R, Decaudin D, J Natl Cancer Inst 2006 98 365 366 16507837 (Pubitemid 43338222)
26. Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different lymphoma sites: significant association with CagA strains of H pylori in gastric MALT. Ye H, Liu H, Attygalle A, Wotherspoon AC, Nicholson AG, Charlotte F, Leblond V, Speight P, Goodlad J, Lavergne-Slove A, Martin-Subero JI, Siebert R, Dogan A, Isaacson PG, Du MQ, Blood 2003 101 2335 2339 10.1182/blood-2002-09-2963 12406890 (Pubitemid 36302078)
27. Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites. Streubel B, Simonitsch-Klupp I, Muellauer L, Lamprecht A, Huber D, Siebert R, Stolte M, Trautinger F, Lukas J, Püspök A, Formanek M, Assanasen T, Müller-Hermelink HK, Cerroni L, Raderer M, Chott A, Leukemia 2004 18 1722 1726 10.1038/sj.leu.2403501 15356642 (Pubitemid 39386353)
28. T(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma. Streubel B, Lamprecht A, Dierlamm J, Cerroni L, Stolte M, Ott G, Raderer M, Chott A, Blood 2003 101 2335 2339 10.1182/blood-2002-09-2963 12406890 (Pubitemid 36302078)
29. No evidence of correlation between BCL10 expression and API2- MALT1 gene rearrangement in ocular adnexal MALT lymphoma. Adachi A, Tamaru J-I, Kaneko K, Kuroda H, Miura I, Kojima T, Hoshino S, Ichinohasama R, Itoyama S, Path Intern 2004 54 16 25 10.1111/j.1440-1827.2004.01580.x (Pubitemid 38979577)
30. Ocular adnexal MALT lymphoma: an intriguing model for antigen-driven lymphomagenesis and microbial-targeted therapy. Ferreri AJ, Dolcetti R, Due M-Q, Ponzoni Kuroda H, Miura I, Kojima T, Hoshino S, Ichinohasama R, Itoyama S, Ann Oncol 2007 19 5 835 846 17986622 (Pubitemid 351627298)
31. Curative radiotherapy for primary orbital lymphoma. Bhatia S, Paulino AC, Buatti JM, Mayr NA, Wen BC, Int J Radiat Oncol Biol Phys 2002 54 3 818 823 10.1016/S0360-3016(02)02966-8 12377334
32. Outcome and prognostic factors in orbital lymphoma: a rare cancer network study on 90 consecutive patients treated with radiotherapy. Martinet S, Ozsahin M, Belkacemi Y, Landmann C, Poortmans P, Oehlere C, Scandolaro L, Krengli M, Maingon P, Miralbell R, Studer G, Chauvet B, Marnitz S, Zouhair A, Mirimanoff RO, Int J Radiat Oncol Biol Phys 2003 55 4 892 898 10.1016/S0360-3016(02)04159-7 12605966 (Pubitemid 36292130)
33. Radiotherapy for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue originating in the ocular adnexa: a multiinstitutional, retrospective review of 50 patients. Uno T, Isobe K, Shikama N, Nishikawa A, Oguchi M, Ueno N, Itami J, Ohnishi H, Mikata A, Ito H, Cancer 2003 98 4 865 871 10.1002/cncr.11539 12910532 (Pubitemid 36959284)
34. Ocular adnexal lymphoma: clinical behavior of distinct world health organization classification subtypes. Fung CY, Tarbell NJ, Lucarelli MJ, Goldberg SI, Linggood RM, Harris NL, Ferry JA, Int J Radiat Oncol Biol Phys 2003 57 5 1382 1391 10.1016/S0360-3016(03)00767-3 14630277 (Pubitemid 37443980)
35. Assessment of disease dissemination in gastric compared with extragastric mucosa-associated lymphoid tissue lymphoma using extensive staging: a single-center experience. Raderer M, Wohrer S, Streubel B, Troch M, Turetschek K, Jäger U, Skrabs C, Gaiger A, Drach J, Puespoek A, Formanek M, Hoffmann M, Hauff W, Chott A, J Clin Oncol 2006 24 19 3136 3141 10.1200/JCO.2006.06.0723 16769982 (Pubitemid 46646224)
36. Impaired response of gastric MALT lymphoma to helicobacter pylori eradication in patients with autoimmune disease. Raderer M, Osterreicher C, Machold K, Formanek M, Fiebiger W, Penz M, Dragosics B, Chott A, Ann Oncol 2001 12 7 937 939 10.1023/A:1011122904602 11521798 (Pubitemid 32725765)
37. Mucosa-associated lymphoid tissue lymphoma with intraocular involvement. Sarraf D, Jain A, Dubovy S, Kreiger A, Fong D, Paschal J, Retina 2005 25 1 94 98 10.1097/00006982-200501000-00018 15655452 (Pubitemid 40250419)
38. Long-term follow-up results of no initial therapy for ocular adnexal MALT lymphoma. Tanimoto K, Kaneko A, Suzuki S, Sekiguchi N, Maruyama D, Kim SW, Watanabe T, Kobayashi Y, Kagami Y, Maeshima A, Matsuno Y, Tobinai K, Ann Oncol 2006 17 1 135 140 16236754 (Pubitemid 43033853)
39. Oral chlorambucil for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue of the orbit. Ben Simon GJ, Cheung N, McKelvie P, Fox R, McNab AA, Ophthalmology 2006 113 7 1209 1213 10.1016/j.ophtha.2006. 01.057 16647129 (Pubitemid 43947228)
40. Long-term follow-up results of observation or radiation for conjunctival malignant lymphoma. Matsuo T, Yoshino T, Ophthalmology 2004 111 6 1233 1237 10.1016/j.ophtha.2003.09.049 15177977 (Pubitemid 38737006)
41. Gastric MALT lymphoma: from aetiology to treatment. Du MQ, Isaccson PG, Lancet Oncol 2002 3 2 97 104 10.1016/S1470-2045(02)00651-4 11902529 (Pubitemid 34162980)
42. Immunoglobulin and T cell receptor beta chain gene rearrangement analysis of ocular adnexal lymphoid neoplasms: clinical and biologic implications. Neri A, Jakobiec FA, Pelicci PG, Dalla-Favera R, Knowles DM, Blood 1987 70 5 1519 1529 3663945 (Pubitemid 18026164)
43. Borrelia burgdorferi-associated cutaneous marginal zone lymphoma: a clinicopathological study of two cases illustrating the temporal progression of B. burgdorferi-associated B-cell proliferation in the skin. Goodlad JR, Davidson MM, Hollowood K, Batstone P, Ho-Yen DO, Histopathology 2000 37 501 508 10.1046/j.1365-2559.2000.01003.x 11122431 (Pubitemid 32099161)
44. Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma. Cerroni L, Zochling N, Putz B, Kerl K, J Cutan Pathol 1997 24 457 461 10.1111/j.1600-0560.1997.tb01318.x 9331890 (Pubitemid 27432373)
45. Borrelia infections of the skin - progress of knowledge since the discovery of Lyme disease. Garbe C, Hautarzt 1991 42 356 365 1917458
46. Deletion analysis of the p16 tumor suppressor gene in gastrointestinal mucosa-associated lymphoid tissue lymphomas. Neumeister P, Hoefler G, Beham-Schmid C, Schmidt H, Apfelbeck U, Schaider H, Linkesch W, Sill H, Gastroenterology 1997 112 6 1871 1875 10.1053/gast.1997.v112.pm9178679 9178679 (Pubitemid 27240773)
47. Simultaneous aberrations of single CDKN2A network components and a high Rb phosphorylation status can differentiate subgroups of primary cutaneous B-cell lymphomas. Kaune KM, Neumann C, Hallermann C, Haller F, Schön MP, Middel P, Exp Dermatol 2011 20 4 331 335 10.1111/j.1600-0625.2010.01226.x 21410763
48. Progression to large B-cell lymphoma in splenic marginal zone lymphoma: a description of a series of 12 cases. Camacho FI, Mollejo M, Mateo MS, Algara P, Navas C, Hernández JM, Santoja C, Solé F, Sánchez-Beato M, Piris MA, Am J Surg Pathol 2001 25 10 1268 1276 10.1097/00000478-200110000- 00007 11688461 (Pubitemid 32917120)
49. Analysis of the P53, RB/D13S25, and P16 tumor suppressor genes in marginal zone B-cell lymphoma: an interphase fluorescence in situ hybridization study. Dierlamm J, Stefanova M, Wlodarska I, Hinz K, Maes B, Michaux L, Stul M, Verhoef G, Thomas J, De Wolf-Peeters C, Van den Berghe H, Hossfeld DK, Hagemeijer A, Cancer Genet Cytogenet 2000 120 1 1 5 10.1016/S0165-4608(99)00239- 3 10913669 (Pubitemid 30410769)
50. Chlamydia infection and lymphomas: association beyond ocular adnexal lymphomas highlighted by multiple detection methods. Ponzoni M, Ferreri AJ, Guidoboni M, Lettini AA, Cangi MG, Pasini E, Sacchi L, Pecciarini L, Grassi S, Dal Cin E, Stefano R, Magnino S, Dolcetti R, Doglioni C, Clin Cancer Res 2008 14 5794 5800 10.1158/1078-0432.CCR-08-0676 18794089
51. Relationship between primary ocular adnexal mucosa-associated lymphoid tissue lymphoma and eye infection. Zhang DD, Liu HG, Li HY, Gao ZF, Zhou XG, Jin HS, Dong LN, Zhang J, Gong LP, Zhonghua Bing Li Xue Za Zhi 2009 38 8 513 518 20021960
52. Association between Sazary T-cell-activating factor, Chlamydia pneumonia, and cutaneus T cell lymphoma. Abrams JT, Balin BJ, Vonderheid EC, Ann N Y Acad Sci 2001 941 69 85 11594584 (Pubitemid 32928335)
53. Detection of Helicobacter pylori and Chlamydia pneumonia genes in primary orbital Lymphoma. Chan CC, Shen D, Mochizuki M, Gonzales JA, Yuen HK, Guex-Crosier Y, Lehoang P, Trans Am Ophthalmol Soc 2006 104 62 70 17471326
54. Chlamydia pneumonia and lung cancer: epidemiologic evidence. Littman AJ, Jackson LA, Vaughan TI, Cancer Epidemiol Biomarkers Prev 2005 14 773 778 10.1158/1055-9965.EPI-04-0599 15824142 (Pubitemid 40478534)
55. Detection of Chlamydia pneumoniae in a Bilateral Orbital Mucosa-Associated Lymphoid Tissue Lymphoma. Shen D, Yuen HK, Galita DA, Chan NR, Chan CC, Am J Ophthalmol 2006 141 6 1162 1163 10.1016/j.ajo.2006.01.067 16765702 (Pubitemid 43831054)
56. Association between Helicobacter pylori infection and MALT-type lymphoma of ocular adnexa: clinical and therapeutic implications. Ferreri AJ, Ponzoni M, Viale E, Guidoboni M, Conciliis CD, Resti AG, Politi L, Lettini AA, Sacchetti F, Dognini G, Dolcetti R, Doglioni C, Hematol Oncol 2006 24 33 37 10.1002/hon.768 16385613
57. The association between conjunctival MALT lymphoma and Helicobacter pylori. Lee SB, Yang JW, Kim CS, Br J Ophtalmol 2008 92 534 536 10.1136/bjo.2007.132316 (Pubitemid 351497985)
58. Chlamydia psittaci, Helicobacter pylori and ocular adnexal lymphoma-is there an association? The German experience. Goebel N, Serr A, Mittelviefhaus H, Reinhard T, Bogdan C, Auw-Haedrich C, Leuk Res 2007 31 1450 1452 10.1016/j.leukres.2006.12.005 17257672 (Pubitemid 47212422)
59. Role of Helicobacter pylori in conjunctival mucosa-associated lymphoid tissue lymphoma. Sjo NC, Foegh P, Juhl BR, Nilsson HO, Prause JU, Ralfkiaer E, Wadström T, Heegaard S, Ophtalmology 2007 114 182 186 10.1016/j.ophtha. 2006.09.020 (Pubitemid 46014312)
60. Extranodal marginal zone lymphoma of the ocular adnexa. Stefanovic A, Lossos IS, Blood 2009 114 3 501 510 10.1182/blood-2008-12-195453 19372259
61. Clinical implications of hepatitis C virus infection in MALTtype lymphoma of the ocular adnexa. Ferreri AJ, Viale E, Guidoboni M, Resti AG, De Conciliis C, Politi L, Lettini AA, Sacchetti F, Dolcetti R, Doglioni C, Ponzoni M, Ann Oncol 2006 17 769 772 10.1093/annonc/mdl027 16524978
62. Prevalence of HCV infection in nongastric marginal zone B-cell lymphoma of MALT. Arcaini L, Burcheri S, Rossi A, Paulli M, Bruno R, Passamonti F, Brusamolino E, Molteni A, Pulsoni A, Cox MC, Orsucci L, Fabbri A, Frezzato M, Voso MT, Zaja F, Montanari F, Merli M, Pascutto C, Morra E, Cortelazzo S, Lazzarino M, Ann Oncol 2007 18 346 350 17071937 (Pubitemid 46323104)
63. Chlamydophila psittaci infections in birds: A rewiew with emphasis on zoonotic consequences. Harkinezhad T, Geens T, Vanrompay D, Vet Microbiol 2009 135 1-2 68 77 10.1016/j.vetmic.2008.09.046 19054633
64. Bacteria-eradicating therapy with doxycycline in ocular adnexal MALT lymphoma: a multicenter prospective trial. Ferreri AJ, Ponzoni M, Guidoboni M, Resti AG, Politi LS, Cortelazzo S, Demeter J, Zallio F, Palmas A, Muti G, Dognini GP, Pasini E, Lettini AA, Sacchetti F, De Conciliis C, Doglioni C, Dolcetti R, J Natl Cancer Inst 2006 98 1375 1382 10.1093/jnci/djj373 17018784 (Pubitemid 44530714)
65. Chlamydia and apoptosis: life and death decisions of an intracellular pathogen. Byrne GI, Ojcius DM, Nat Rev Microbiol 2004 2 802 808 10.1038/nrmicro1007 15378044 (Pubitemid 39317461)
66. B cell response in Chlamydia trachomatis endometritis. Lehtinen M, Rantala I, Aine R, Miettinen A, Laine S, Heinonen P, Teisala K, Punnonen R, Paavonen J, Eur J Clin Microbiol 1986 5 596 598 10.1007/BF02017713 3490976 (Pubitemid 17202066)
67. Chlamydia and programmed cell death. Miyairi I, Byrne GI, Curr Opin Microbiol 2006 9 102 108 10.1016/j.mib.2005.12.004 16406838 (Pubitemid 43184343)
68. Infectious agents and lymphoma development: molecular and clinical aspects. Ferreri AJ, Ernberg I, Copie-Bergman C, J Intern Med 2009 265 421 438 10.1111/j.1365-2796.2009.02083.x 19298458
69. Heat shock proteins as regulators of the immune response. Pockley AG, Lancet 2003 362 9382 469 476 10.1016/S0140-6736(03)14075-5 12927437 (Pubitemid 36999714)
70. Immunoglobulin G1 antibody response to helicobacter pylori heat shock protein 60 is closely associated with low-grade gastric mucosa-associated lymphoid tissue lymphoma. Ishii E, Yokota K, Sugiyama T, Fujinaga Y, Ayada K, Hokari I, Hayashi S, Hirai Y, Asaka M, Oguma K, Clin Diagn Lab Immunol 2001 8 6 1056 1059 11687439 (Pubitemid 33035731)
71. Helicobacter pylori infection. Suerbaum S, Michetti P, N Engl J Med 2002 347 1175 1186 10.1056/NEJMra020542 12374879
72. Inflammation and oxidative stress in carcinogenesis. Cerutti PA, Trump BF, Cancer Cells 1991 3 1 7 2025490
73. Molecular Aspects of H. pylori-Related MALT Lymphoma. Owens SR, Smith LB, Patholog Res Int 2011 2011 193149 21318155
74. Gastric low-grade mucosal-associated lymphoid tissue-lymphoma: Helicobacter pylori and beyond. Zullo A, Hassan C, Cristofari F, Perri F, Morini S, World J Gastrointest Oncol 2010 2 4 181 186 10.4251/wjgo.v2.i4.181 21160595
75. Common threads of mucosa-associated lymphoid tissue lymphoma pathogenesis: from infection to translocation. Jaffe ES, J Natl Cancer Inst 2004 96 8 571 573 10.1093/jnci/djh138 15100327 (Pubitemid 38584974)
76. Extranodal marginal zone lymphomas of the ocular adnexa. Multiparameter analysis of 34 cases including interphase molecular cytogenetics and PCR for Chlamydia psittaci. Ruiz A, Reischl U, Swerdlow SH, Hartke M, Streubel B, Procop G, Tubbs RR, Cook JR, Am J Surg Pathol 2007 31 792 802 10.1097/01.pas. 0000249445.28713.88 17460465 (Pubitemid 46684221)
77. Assessment of the role of hepatitis C, Helicobacter phylori and autoimmunity in MALT lymphoma of the ocular adnexa in 45 Austrian patients. Gruenberger B, Woehrer S, Troch M, Hauff W, Lukas J, Streubel B, Muellauer L, Chott A, Raderer M, Acta Oncologica 2008 47 355 359 10.1080/02841860701630283 17957504 (Pubitemid 351414918)
78. Fluorescence in situ hybridization (FISH) analysis of primary ocular adnexal MALT lymphoma. Tanimoto K, Sekiguchi N, Yokota Y, Kaneko A, Watanabe T, Maeshima AM, Matsuno Y, Harada M, Tobinai K, Kobayashi Y, BMC Cancer 2006 6 249 258 10.1186/1471-2407-6-249 17052360 (Pubitemid 44696824)
79. Typical genomic imbalance in primary MALT lymphoma of the orbit. Matteucci C, Galieni P, Leoncini L, Lazzi S, Lauria F, Polito E, Martelli MF, Mecucci C, J Pathol 2003 200 5 656 660 10.1002/path.1386 12898603 (Pubitemid 36987316)
80. The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas. Dierlamm J, Baens M, Wlodarska I, Stefanova-Ouzounova M, Hernandez JM, Hossfeld DK, De Wolf-Peeters C, Hagemeijer A, Van den Berghe H, Marynen P, Blood 1999 93 11 3601 3609 10339464 (Pubitemid 29249804)
81. A novel gene, MALT1 at 18q21, is involved in t(11;18) (q21;q21) found in low-grade B-cell lymphoma of mucosa-associated lymphoid tissue. Akagi T, Motegi M, Tamura A, Suzuki R, Hosokawa Y, Suzuki H, Ota H, Nakamura S, Morishima Y, Taniwaki M, Seto M, Oncogene 1999 18 42 5785 5794 10.1038/sj.onc.1203018 10523859 (Pubitemid 29507432)
82. Breakpoints of the t(11;18)(q21;q21) in mucosa-associated lymphoid tissue (MALT) lymphoma lie within or near the previously undescribed gene MALT1 in chromosome 18. Morgan JA, Yin Y, Borowsky AD, Kuo F, Nourmand N, Koontz JI, Reynolds C, Soreng L, Griffin CA, Graeme-Cook F, Harris NL, Weisenburger D, Pinkus GS, Fletcher JA, Sklar J, Cancer Res 1999 59 24 6205 6213 10626814 (Pubitemid 30035644)
83. MALT lymphoma: many roads lead to nuclear factor-kb activation. Du MQ, Histopathology 2011 58 26 38 10.1111/j.1365-2559.2010.03699.x 21261681
84. Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-kappa B signaling pathway. Lucas PC, Yonezumi M, Inohara N, McAllister-Lucas LM, Abazeed ME, Chen FF, Yamaoka S, Seto M, Nunez G, J Biol Chem 2001 276 22 19012 19019 10.1074/jbc.M009984200 11262391
85. Identification of paracaspases and metacaspases: two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma. Uren AG, O'Rourke K, Aravind LA, Pisabarro MT, Seshagiri S, Koonin EV, Dixit VM, Mol Cell 2000 6 4 961 967 11090634
86. Bcl10 is a positive regulator of antigen receptor-induced activation of NF-kappaB and neural tube closure. Ruland J, Duncan GS, Elia A, Del Barco Barrantes I, Nguyen L, Plyte S, Millar DG, Bouchard D, Wakeham A, Ohashi PS, Mak TW, Cell 2001 104 33 42 10.1016/S0092-8674(01)00189-1 11163238 (Pubitemid 32144970)
87. Defective development and function of Bcl10-deficient follicular, marginal zone and B1 B cells. Xue L, Morris SW, Orihuela C, Tuomanen E, Cui X, Wen R, Wang D, Nat Immunol 2003 4 857 865 10.1038/ni963 12910267 (Pubitemid 37098656)
88. CARMA1, BCL-10 and MALT1 in lymphocyte development and activation. Thome M, Nat Rev Immunol 2004 4 348 359 10.1038/nri1352 15122200 (Pubitemid 38649277)
89. Cell cycle deregulation in B-cell lymphomas. Sanchez-Beato M, Sanchez-Aguilera A, Piris MA, Blood 2003 101 1220 1235 10.1182/blood-2002-07- 2009 12393483 (Pubitemid 36182489)
90. Characterization of bcl10 as a potential transcriptional activator that interacts with general transcription factor TFIIB. Liu Y, Dong W, Chen L, Zhang P, Qi Y, Biochem Biophys Res Commun 2004 320 1 6 10.1016/j.bbrc.2004.05.112 15207693 (Pubitemid 38781776)
91. NF-kB and Rel proteins: evolutionarily conserved mediators of immune responses. Ghosh S, May MJ, Kopp EB, Annu Rev Immunol 1998 16 225 260 10.1146/annurev.immunol.16.1.225 9597130 (Pubitemid 28183365)
92. An N-terminal nuclear export signal is required for the nucleocytoplasmic shuttling of IkBalpha. Johnson C, Van Antwerp D, Hope TJ, EMBO J 1999 18 6682 6693 10.1093/emboj/18.23.6682 10581242
93. Phosphorylation meets ubiquitination: the control of NF-kB activity. Karin M, Ben-Neriah Y, Annu Rev Immunol 2000 18 621 663 10.1146/annurev.immunol. 18.1.621 10837071 (Pubitemid 30365393)
94. Genomic DNA-chip hybridization reveals a higher incidence of genomic amplifications in pancreatic cancer than conventional comparative genomic hybridization and leads to the identification of novel candidate genes. Holzmann K, Kohlhammer H, Schwaenen C, Wessendorf S, Kestler HA, Schwoerer A, Rau B, Radlwimmer B, Döhner H, Lichter P, Gress T, Bentz M, Cancer Res 2004 64 4428 4433 10.1158/0008-5472.CAN-04-0431 15231651 (Pubitemid 38856913)
95. MALT lymphoma with t(14;18) (q32;q21)/IGH-MALT1 is characterized by strong cytoplasmatic MALT1 and bcl10 expression. Ye H, Gong L, Liu H, Hamoudi RA, Shirali S, Ho L, Chott A, Streubel B, Siebert R, Gesk S, Martin-Subero JI, Radford JA, Banerjee S, Nicholson AG, Ranaldi R, Remstein ED, Gao Z, Zheng J, Isaacson PG, Dogan A, Du MQ, J Pathol 2005 205 293 301 10.1002/path.1715 15682443 (Pubitemid 40253919)
96. Molecular pathophysiology of indolent lymphoma. Capello D, Gaidano G, Haematologica 2000 85 195 201 10681729 (Pubitemid 30366665)
97. Nuclear expression of bcl10 or nuclear factor kappa B predicts Helicobacter pylori-independent status of early-stage, highgrade gastric mucosa-associated lymphoid tissue lymphomas. Kuo SH, Chen LT, Yeh KH, Wu MS, Hsu HC, Yeh PY, MAO TL, Chen CL, Doong SL, Lin JT, Cheng AL, J Clin Oncol 2004 22 3491 3497 10.1200/JCO.2004.10.087 15337797 (Pubitemid 41103655)
98. Nuclear BCL10 expression is common in lymphoplasmacytic lymphomas/Waldenstrom macroglobulinemia and does not correlate with p65 NF-kB activation. Merzianu M, Jiang L, Lin P, Wang X, Weber DM, Vadhan-Raj S, Nguyen MH, Medeiros LJ, Bueso-Ramos CE, Mod Pathol 2006 19 891 898 10.1038/modpathol. 3800609 16636680
99. T(3;14) (p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma. Streubel B, Vinatzer U, Lamprecht A, Raderer M, Chott A, Leukemia 2005 19 4 652 658 15703784 (Pubitemid 40521171)
100. Genetic rearrangement of FOXP1 is predominantly detected in a subset of diffuse large B cell lymphomas with extranodal presentation. Haralambieva E, Adam P, Ventura R, Katzenberger T, Kalla J, Höller S, Hartmann M, Rosenwald A, Greiner A, Muller-Hermelink HK, Banham AH, Ott G, Leukemia 2006 20 7 1300 1303 10.1038/sj.leu.2404244 16673020 (Pubitemid 43905839)
101. Mucosa-associated lymphoid tissue lymphoma: novel translocations involving ODZ2, JMJD2C and CNN3. Vinatzer U, Gollinger M, Mullauer L, Raderer M, Chott A, Streubel B, Clin Canc Res 2008 21 902 911
102. Ocular Adnexal Lymphomas: a rewiew. McKelvie PA, Adv Anat Pathol 2010 17 251 261 10.1097/PAP.0b013e3181e4abdb 20574170
103. Translocation (5;11) in a conjunctival MALT lymphoma. Clement CG, Potluri VR, Gonzales J, Qian YW, Int J Clin Exp Pathol 2011 4 7 722 726 22076174
104. TNFAIP3 is the target gene of chromosome band 6q23.3-q24.1 loss in ocular adnexal marginal zone B cell lymphoma. Honma K, Tsuzuki S, Nakagawa M, Karnan S, Aizawa Y, Kim WS, Kim YD, Ko YH, Seto M, Genes Chromosomes Cancer 2008 47 1 1 7 10.1002/gcc.20499 17886247 (Pubitemid 350191458)
105. A20 is targeted by promoter methylation, deletion and inactivating mutation in MALT lymphoma. Chanudet E, Huang Y, Ichimura K, Dong G, Hamoudi RA, Radford J, Wotherspoon AC, Isaacson PG, Ferry J, Du MQ, Leukemia 2010 24 2 483 487 10.1038/leu.2009.234 19907439
106. The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas. Novak U, Rinaldi A, Kwee I, Nandula SV, Rancoita PM, Compagno M, Cerri M, Rossi D, Murty VV, Zucca E, Gaidano G, Dalla-Favera R, Pasqualucci L, Bhagat G, Bertoni F, Blood 2009 113 20 4918 4921 10.1182/blood-2008-08-174110 19258598
107. Frequent inactivation of A20 in B-cell lymphomas. Kato M, Sanada M, Kato I, Sato Y, Takita J, Takeuchi K, Niwa A, Chen Y, Nakazaki K, Nomoto J, Asakura Y, Muto S, Tamura A, Iio M, Akatsuka Y, Hayashi Y, Mori H, Igarashi T, Kurokawa M, Chiba S, Mori S, Ishikawa Y, Okamoto K, Tobinai K, Nakagama H, Nakahata T, Yoshino T, Kobayashi Y, Ogawa S, Nature 2009 459 7247 712 716 10.1038/nature07969 19412163
108. A20 deletion is associated with copy number gain at the TNFA/B/C locus and occurs preferentially in translocation-negative MALT lymphoma of the ocular adnexa and salivary glands. Chanudet E, Ye H, Ferry J, Bacon CM, Adam P, Müller-Hermelink HK, Radford J, Pileri SA, Ichimura K, Collins VP, Hamoudi RA, Nicholson AG, Wotherspoon AC, Isaacson PG, Du MQ, J Pathol 2009 217 3 420 430 10.1002/path.2466 19006194
109. Genome-wide array-based comparative genomic hybridization of ocular marginal zone B cell lymphoma: comparison with pulmonary and nodal marginal zone B cell lymphoma. Kim WS, Honma K, Karnan S, Tagawa H, Kim YD, Oh YL, Seto M, Ko YH, Genes Chromosomes Cancer 2007 46 8 776 783 10.1002/gcc.20463 17492759 (Pubitemid 46912348)
110. The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology. Vereecke L, Beyaert R, van Loo G, Trends Immunol 2009 30 8 383 391 10.1016/j.it.2009.05.007 19643665
111. Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus. Graham RR, Cotsapas C, Davies L, Hackett R, Lessard CJ, Leon JM, Burtt NP, Guiducci C, Parkin M, Gates C, Plenge RM, Behrens TW, Wither JE, Rioux JD, Fortin PR, Graham DC, Wong AK, Vyse TJ, Daly MJ, Altshuler D, Moser KL, Gaffney PM, Nat Genet 2008 40 9 1059 1061 10.1038/ng.200 19165918
112. Analysis of TNFAIP3, a feedback inhibitor of nuclear factor-kappaB and the neighbor intergenic 6q23 region in rheumatoid arthritis susceptibility. Dieguez-Gonzalez R, Calaza M, Perez-Pampin E, Balsa A, Blanco FJ, Cãete JD, Caliz R, Carrẽo L, de la Serna AR, Fernandez-Gutierrez B, Ortiz AM, Herrero-Beaumont G, Pablos JL, Narvaez J, Navarro F, Marenco JL, Gomez-Reino JJ, Gonzalez A, Arthritis Res Ther 2009 11 2 42 10.1186/ar2650 19292917
113. Two independent alleles at 6q23 associated with risk of rheumatoid arthritis. Plenge RM, Cotsapas C, Davies L, Price AL, de Bakker PI, Maller J, Pe'er I, Burtt NP, Blumenstiel B, DeFelice M, Parkin M, Barry R, Winslow W, Healy C, Graham RR, Neale BM, Izmailova E, Roubenoff R, Parker AN, Glass R, Karlson EW, Maher N, Hafler DA, Lee DM, Seldin MF, Remmers EF, Lee AT, Padyukov L, Alfredsson L, Coblyn J, et al. Nat Genet 2007 39 12 1477 1482 10.1038/ng.2007.27 17982456 (Pubitemid 350191346)
114. Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus. Musone SL, Taylor KE, Lu TT, Nititham J, Ferreira RC, Ortmann W, Shifrin N, Petri MA, Kamboh MI, Manzi S, Seldin MF, Gregersen PK, Behrens TW, Ma A, Kwok PY, Criswell LA, Nat Genet 2008 40 9 1062 1064 10.1038/ng.202 19165919
115. Results of radiotherapy for orbital and adnexal lymphoma. Liao SL, Kao SC, Hou PK, Chen MS, Orbit 2002 21 117 123 10.1076/orbi.21.2.117.7192 12029566 (Pubitemid 34620824)
116. Efficacy of chemotherapy as first-line treatment in ocular adnexal extranodal marginal zone B cell lymphoma. Song EK, Kim SY, Kim TM, Lee KW, Yun T, Na II, Shin H, Lee SH, Kim DW, Khwarg SI, Heo DS, Ann Oncol 2008 19 242 246 10.1093/annonc/mdm457 17947227 (Pubitemid 351201703)
117. Treatment options in ocular adnexa lymphoma (OAL). Cohen VM, Clin Ophthalmol 2009 3 689 692 20054418
118. Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type. Conconi A, Martinelli G, Thieblemont C, Ferreri AJ, Devizzi L, Peccatori F, Ponzoni M, Pedrinis E, Dell'Oro S, Pruneri G, Filipazzi V, Dietrich PY, Gianni AM, Coiffier B, Cavalli F, Zucca E, Blood 2003 102 8 2741 2745 10.1182/blood-2002-11-3496 12842999 (Pubitemid 37248842)
119. Anti-CD20 monoclonal antibody therapy in relapsed MALT lymphoma of the conjunctiva. Nuckel H, Meller D, Steuhl KP, Dührsen U, Eur J Haematol 2004 73 4 258 262 10.1111/j.1600-0609.2004.00299.x 15347312 (Pubitemid 39294690)
120. Rituximab in patients with mucosalassociated lymphoid tissue-type lymphoma of the ocular adnexa. Ferreri AJ, Ponzoni M, Martinelli G, Muti G, Guidoboni M, Dolcetti R, Doglioni C, Haematologica 2005 90 11 1578 1579 16266908
121. MALT lymphoma: from morphology to molecules. Isaacson PG, Du MQ, Nat Rev Cancer 2004 4 8 644 653 10.1038/nrc1409 15286744 (Pubitemid 39025059)
122. Meta-analyses of the association between Chlamydia psittaci and ocular adnexal lymphoma and the response of ocular adnexal lymphoma to antibiotics. Husain A, Roberts D, Pro B, McLaughlin P, Esmaeli B, Cancer 2007 110 809 815 10.1002/cncr.22843 17594698 (Pubitemid 47257658)
123. Periocular mucosa-associated lymphoid/low grade lymphomas: treatment with antibiotics. Abramson DH, Rollins I, Coleman M, Am J Ophthalmol 2005 140 729 730 10.1016/j.ajo.2005.03.060 16226528 (Pubitemid 41455321)
124. 'Blind' antibiotic treatment targeting Chlamydia is not effective in patients with MALT lymphoma of the ocular adnexa. Grunberger B, Hauff W, Lukas J, Wöhrer S, Zielinski CC, Streubel B, Chott A, Raderer M, Ann Oncol 2006 17 484 487 10.1093/annonc/mdj143 16500916 (Pubitemid 43329587)
125. First-line therapy with doxycycline in ocular adnexal mucosa-associated lymphoid tissue lymphoma: a retrospective analysis of clinical predictors. Kim TM, Kim KH, Lee MJ, Jeon YK, Lee SH, Kim DW, Kim CW, Kim IH, Khwarg SI, Heo DS, Cancer Sci 2010 101 5 1199 1203 10.1111/j.1349-7006.2010.01502.x 20345477
126. Chlamydia-psittaci-eradicating antibiotic therapy in patients with advanced-stage ocular adnexal MALT lymphoma. Ferreri AJ, Dognini GP, Ponzoni M, Pecciarini L, Cangi MG, Santambrogio G, Resti AG, De Conciliis C, Magnino S, Pasini E, Vicari N, Dolcetti R, Doglioni C, Ann Oncol 2008 19 1 194 195 18073219